MedPath

吉林万通药业有限公司

Ownership
-
Established
2006-12-29
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

56

NMPA:56

Drug Approvals

Ethylenediamine Diaceturate for Injection

Product Name
虹伊宁
Approval Number
国药准字H20050423
Approval Date
Jun 29, 2023
NMPA

Dexamethasone Acetate Tablets

Product Name
醋酸地塞米松片
Approval Number
国药准字H22021224
Approval Date
Jun 15, 2022
NMPA

Prednisone Acetate Tablets

Product Name
醋酸泼尼松片
Approval Number
国药准字H22021337
Approval Date
Jun 15, 2022
NMPA

Aceglutamide for Injection

Product Name
注射用乙酰谷酰胺
Approval Number
国药准字H20050185
Approval Date
Jun 15, 2022
NMPA

Betamethasone Tablets

Product Name
倍他米松片
Approval Number
国药准字H22021221
Approval Date
Jun 15, 2022
NMPA

Cefalexin Tablets

Product Name
头孢氨苄片
Approval Number
国药准字H22021228
Approval Date
Dec 20, 2021
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H22021336
Approval Date
Apr 22, 2021
NMPA

金海清咽袋泡茶

Approval Number
国药准字B20020794
Approval Date
Dec 21, 2020
NMPA

Vitamin B Complex Tablets

Product Name
复合维生素B片
Approval Number
国药准字H20057239
Approval Date
Sep 29, 2020
NMPA

Compound Paracetamol and Chlorphenamine Maleate Granules

Product Name
复方氨酚那敏颗粒
Approval Number
国药准字H14023065
Approval Date
Aug 28, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.